SINOVAC BIOTECH LTD Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
SINOVAC BIOTECH LTD (SVA) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $112.93 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-06-05
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month as first filed |
|---|---|---|
| 2025-12-31 | $112.93M 20-F · filed 2026-06-05 | |
| 2024-12-31 | -$102.42M 20-F · filed 2026-06-05 | |
| 2023-12-31 | -$108.85M 20-F · filed 2026-06-05 | -$114.90M 20-F · filed 2024-04-29 |
| 2022-12-31 | -$540.93M 20-F · filed 2026-04-30 | -$560.77M 20-F · filed 2023-05-01 |
| 2021-12-31 | $135.72M 20-F · filed 2026-04-30 | $137.27M 20-F · filed 2022-04-29 |
| 2020-12-31 | $27.21M 20-F · filed 2023-05-01 | |
| 2019-12-31 | -$649.00K 20-F · filed 2022-04-29 | |
| 2018-12-31 | -$4.66M 20-F · filed 2021-04-22 | |
| 2017-12-31 | $4.00M 20-F · filed 2020-04-30 | |
| 2016-12-31 | -$2.27M 20-F · filed 2019-04-29 |